| 摘要 |
The present invention relates to a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, or a combination thereof; wherein R°, R<SUP>1</SUP>, R<SUP>1'</SUP>, R<SUP>2</SUP>, R<SUP>2'</SUP>, R<SUP>3</SUP> and n are defined herein. The present invention further relates to a method of treating a patient from endometreosis or uterine fibroids.
|
| 申请人 |
SMITHKLINE BEECHAM CORPORATION;JONES, DAVID, G.;KALDOR, ISTVAN;LIANG, XI;TURNBULL, PHILIP, STEWART;HAMMOND, MARLYS;KALLANDER, LARA, S.;THOMPSON, SCOTT, KEVIN;WASHBURN, DAVID |
发明人 |
JONES, DAVID, G.;KALDOR, ISTVAN;LIANG, XI;TURNBULL, PHILIP, STEWART;HAMMOND, MARLYS;KALLANDER, LARA, S.;THOMPSON, SCOTT, KEVIN;WASHBURN, DAVID |
